Skip to main content
Erschienen in: Current Treatment Options in Gastroenterology 3/2018

13.07.2018 | Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)

Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD

verfasst von: Anita Afzali, MD, MPH, FACG, Seymour Katz, MD, FACP, MACG

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Early- and late-onset of inflammatory bowel disease (IBD) may perhaps be etiologically distinct and potentially attributed to genetics, environmental or microbial factors. We review disease factors and clinical characteristics, as well as unique management and treatment strategies to consider when caring for the “baby” or “baby boomer” with IBD.

Recent findings

Around 25% of cases of initial diagnosis of IBD is made before the age of 18 years old, and another 15–20% made after the age of 60. Crohn’s disease (CD) typically presents as ileocolonic and stricturing or penetrating phenotype among early-onset, whereas among late-onset, it is mainly colonic and inflammatory. Pediatric ulcerative colitis (UC) is mostly pan-colonic versus primarily left-sided among the elderly. Treatment goal for both age groups is primarily symptom control, with growth and development also considered among pediatric patients. Due to alterations in pharmacokinetics, careful monitoring and reduced dose should be considered. A multidisciplinary care team is necessary to ensure better clinical outcomes.

Summary

Onset of disease at either spectrum of age requires careful management and treatment, with both unique disease- and age-appropriate factors carefully considered.
Literatur
1.
Zurück zum Zitat Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–94.CrossRefPubMed Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–94.CrossRefPubMed
2.
Zurück zum Zitat Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel disease with time, based on systematic review. Gastroenterology. 2012;142:46–54.CrossRefPubMed Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel disease with time, based on systematic review. Gastroenterology. 2012;142:46–54.CrossRefPubMed
3.
Zurück zum Zitat Sandler RS, Eisen GM. Epidemiology of inflammatory bowel disease. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia: Saunders; 2000. p. 89–112. Sandler RS, Eisen GM. Epidemiology of inflammatory bowel disease. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia: Saunders; 2000. p. 89–112.
4.
Zurück zum Zitat Shashidar H, Integlia MJ, Grand RJ. Clinical manifestations of pediatric inflammatory bowel disease. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia: Saunders; 2000. p. 326–34. Shashidar H, Integlia MJ, Grand RJ. Clinical manifestations of pediatric inflammatory bowel disease. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia: Saunders; 2000. p. 326–34.
5.
Zurück zum Zitat • Benchimol EI, Mack DR, Nguyen GC, et al. Incidence, outcomes and health services burden of very early onset of inflammatory bowel disease. Gastroenterology. 2014;147:803–13. Summarizes disease characteristics and outcomes of early and very early onset of IBD.CrossRefPubMed • Benchimol EI, Mack DR, Nguyen GC, et al. Incidence, outcomes and health services burden of very early onset of inflammatory bowel disease. Gastroenterology. 2014;147:803–13. Summarizes disease characteristics and outcomes of early and very early onset of IBD.CrossRefPubMed
6.
Zurück zum Zitat •• Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Aliment Pharmacol Ther. 2014;39:459–77. This review summarizes disease characteristics and management of the elderly with IBD.CrossRefPubMed •• Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Aliment Pharmacol Ther. 2014;39:459–77. This review summarizes disease characteristics and management of the elderly with IBD.CrossRefPubMed
7.
Zurück zum Zitat Ruel J, Ruane D, Mehandru S, et al. IBD across the age spectrum—is it the same disease? Nat Rev Gastroenterol Hepatol. 2013;11:88–98.CrossRefPubMed Ruel J, Ruane D, Mehandru S, et al. IBD across the age spectrum—is it the same disease? Nat Rev Gastroenterol Hepatol. 2013;11:88–98.CrossRefPubMed
8.
Zurück zum Zitat Afzali A, Cross RK. Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis. 2016;22:2023–40.CrossRefPubMed Afzali A, Cross RK. Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis. 2016;22:2023–40.CrossRefPubMed
9.
Zurück zum Zitat Louis E. When it is not inflammatory bowel disease: differential diagnosis. Curr Opin Gastroenterol. 2015;31:283–9.CrossRefPubMed Louis E. When it is not inflammatory bowel disease: differential diagnosis. Curr Opin Gastroenterol. 2015;31:283–9.CrossRefPubMed
10.
Zurück zum Zitat Dabritz J, Gerner P, Enninger A, et al. Inflammatory bowel disease in childhood and adolescence. Dtsch Arztebl Int. 2017;114:331–8.PubMedPubMedCentral Dabritz J, Gerner P, Enninger A, et al. Inflammatory bowel disease in childhood and adolescence. Dtsch Arztebl Int. 2017;114:331–8.PubMedPubMedCentral
13.
Zurück zum Zitat Harper PC, McAuliffe TL, Beeken WL. Crohn’s disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med. 1986;146:753–5.CrossRefPubMed Harper PC, McAuliffe TL, Beeken WL. Crohn’s disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med. 1986;146:753–5.CrossRefPubMed
14.
Zurück zum Zitat Wagtmans MJ, Verspaget HW, Lamers CB, et al. Crohn’s disease in the elderly: a comparison with young adults. J Clin Gastroenterol. 1998;27:129–33.CrossRefPubMed Wagtmans MJ, Verspaget HW, Lamers CB, et al. Crohn’s disease in the elderly: a comparison with young adults. J Clin Gastroenterol. 1998;27:129–33.CrossRefPubMed
15.
Zurück zum Zitat Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2013;58:519–25.CrossRefPubMed Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2013;58:519–25.CrossRefPubMed
16.
Zurück zum Zitat Virta LJ, Saarinen MM, Kolho KL. Inflammatory bowel disease incidence is on the continuous rise among all paediatric patients except for the very young: a nationwide registry-based study on 28-year follow up. J Crohn's Colitis. 2017;11:150–6.CrossRef Virta LJ, Saarinen MM, Kolho KL. Inflammatory bowel disease incidence is on the continuous rise among all paediatric patients except for the very young: a nationwide registry-based study on 28-year follow up. J Crohn's Colitis. 2017;11:150–6.CrossRef
17.
Zurück zum Zitat Gasparetto M and Guariso G. Gastroenterology research and practice. Volume 2013, Article ID 829040, 12 pages. Gasparetto M and Guariso G. Gastroenterology research and practice. Volume 2013, Article ID 829040, 12 pages.
18.
Zurück zum Zitat Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007;13:254–61.CrossRefPubMed Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007;13:254–61.CrossRefPubMed
19.
Zurück zum Zitat Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–9.CrossRefPubMed Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–9.CrossRefPubMed
20.
Zurück zum Zitat Ananthakrishnan AN, McGinley EL, Binion DG, et al. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009;15:182–9.CrossRefPubMed Ananthakrishnan AN, McGinley EL, Binion DG, et al. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009;15:182–9.CrossRefPubMed
21.
Zurück zum Zitat Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014;63:423–32.CrossRefPubMed Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014;63:423–32.CrossRefPubMed
22.
Zurück zum Zitat Manosa M, Calafat M, de Frandisco R, et al. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicenter, case-control study. Aliment Pharmacol Ther. 2018:1–10. Manosa M, Calafat M, de Frandisco R, et al. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicenter, case-control study. Aliment Pharmacol Ther. 2018:1–10.
23.
Zurück zum Zitat Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence and survival. Gut. 2000;46:336–43.CrossRefPubMedPubMedCentral Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence and survival. Gut. 2000;46:336–43.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence and survival. Gastroenterology. 1998;114:1161–8.CrossRefPubMed Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence and survival. Gastroenterology. 1998;114:1161–8.CrossRefPubMed
25.
Zurück zum Zitat Jeuring SF, Van den Heuvel TR, Zeegers MP, et al. Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age—an increasing distinct entity? Inflamm Bowel Dis. 2016;22:1425–34.CrossRefPubMed Jeuring SF, Van den Heuvel TR, Zeegers MP, et al. Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age—an increasing distinct entity? Inflamm Bowel Dis. 2016;22:1425–34.CrossRefPubMed
26.
Zurück zum Zitat Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, et al. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis. 2013;45:89–94.CrossRefPubMed Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, et al. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis. 2013;45:89–94.CrossRefPubMed
27.
Zurück zum Zitat Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, et al. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn’s disease. Am J Gastroenterol. 2007;102:2804–12.CrossRefPubMed Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, et al. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn’s disease. Am J Gastroenterol. 2007;102:2804–12.CrossRefPubMed
28.
Zurück zum Zitat Hyam J, Crandall W, Kugathasan S, et al. REACH Study Group. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children. Gastroenterology. 2007;132:863–73.CrossRef Hyam J, Crandall W, Kugathasan S, et al. REACH Study Group. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children. Gastroenterology. 2007;132:863–73.CrossRef
29.
Zurück zum Zitat Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of pediatric IBD consortium registry. J Pediatr. 2005;146:35–40.CrossRefPubMed Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of pediatric IBD consortium registry. J Pediatr. 2005;146:35–40.CrossRefPubMed
30.
Zurück zum Zitat Paul TM, Birnbaum AM, Pal DKP, et al. Distinct phenotype of early childhood inflammatory bowel disease. J Clin Gastroenterol. 2006;40:583–6.CrossRefPubMed Paul TM, Birnbaum AM, Pal DKP, et al. Distinct phenotype of early childhood inflammatory bowel disease. J Clin Gastroenterol. 2006;40:583–6.CrossRefPubMed
31.
Zurück zum Zitat Limbergen JV, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135:1114–22.CrossRefPubMed Limbergen JV, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135:1114–22.CrossRefPubMed
32.
33.
Zurück zum Zitat Meinzer U, Idestrom M, Alberti C, et al. Ileal involvement is age dependent in pediatric Crohn’s disease. Inflamm Bowel Dis. 2005;11:639–44.CrossRefPubMed Meinzer U, Idestrom M, Alberti C, et al. Ileal involvement is age dependent in pediatric Crohn’s disease. Inflamm Bowel Dis. 2005;11:639–44.CrossRefPubMed
34.
Zurück zum Zitat Shaoul R, Karban A, Reif S, Weiss B, Shamir R, Tamir A, et al. Disease behavior in children with Crohn’s disease: the effect of disease duration, ethnicity, genotype, and phenotype. Dig Dis Sci. 2009;54:142–50.CrossRefPubMed Shaoul R, Karban A, Reif S, Weiss B, Shamir R, Tamir A, et al. Disease behavior in children with Crohn’s disease: the effect of disease duration, ethnicity, genotype, and phenotype. Dig Dis Sci. 2009;54:142–50.CrossRefPubMed
35.
Zurück zum Zitat Mamula P, Telega GW, Markowitz JE, Brown KA, Russo PA, Piccoli DA, et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol. 2002;97:2005–10.CrossRefPubMed Mamula P, Telega GW, Markowitz JE, Brown KA, Russo PA, Piccoli DA, et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol. 2002;97:2005–10.CrossRefPubMed
36.
Zurück zum Zitat Prenzel F, Uhlig HH. Frequency of indeterminate colitis in children and adults with IBD – a meta-analysis. J Crohns Colitis. 2009;3:277–81.CrossRefPubMed Prenzel F, Uhlig HH. Frequency of indeterminate colitis in children and adults with IBD – a meta-analysis. J Crohns Colitis. 2009;3:277–81.CrossRefPubMed
37.
Zurück zum Zitat Aloi M, Lionetti P, Barabino A, Guariso G, Costa S, Fontana M, et al. Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:597–605.CrossRefPubMed Aloi M, Lionetti P, Barabino A, Guariso G, Costa S, Fontana M, et al. Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:597–605.CrossRefPubMed
38.
Zurück zum Zitat Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168:149–55.CrossRefPubMed Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168:149–55.CrossRefPubMed
39.
Zurück zum Zitat Ruemmele FM, El Khoury MG, Talbotec C, et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr. 2006;43:603–9.CrossRefPubMed Ruemmele FM, El Khoury MG, Talbotec C, et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr. 2006;43:603–9.CrossRefPubMed
40.
Zurück zum Zitat • Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris Classification. Inflamm Bowel Dis. 2011;17:1314–21. Given differences in disease characteristics and natural course history of early and very-early onset of IBD, the authors propose a modification of the Montreal classification of IBD.CrossRefPubMed • Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris Classification. Inflamm Bowel Dis. 2011;17:1314–21. Given differences in disease characteristics and natural course history of early and very-early onset of IBD, the authors propose a modification of the Montreal classification of IBD.CrossRefPubMed
41.
Zurück zum Zitat Muise AM, Snapper SB, Kugathasan S. The age of gene discovery in very early onset inflammatory bowel disease. Gastroenterology. 2012;143:285–8.CrossRefPubMed Muise AM, Snapper SB, Kugathasan S. The age of gene discovery in very early onset inflammatory bowel disease. Gastroenterology. 2012;143:285–8.CrossRefPubMed
42.
Zurück zum Zitat Greth J, Torok HP, Koenig A, et al. Comparison of inflammatory bowel disease at younger and older age. Eur J Med Res. 2004;9:552–4.PubMed Greth J, Torok HP, Koenig A, et al. Comparison of inflammatory bowel disease at younger and older age. Eur J Med Res. 2004;9:552–4.PubMed
43.
Zurück zum Zitat Polito JM, Childs B, Mellits ED, et al. Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology. 1996;111:580–6.CrossRefPubMed Polito JM, Childs B, Mellits ED, et al. Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology. 1996;111:580–6.CrossRefPubMed
44.
Zurück zum Zitat Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. J Crohns Colitis. 2011;5:5–13.CrossRefPubMed Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. J Crohns Colitis. 2011;5:5–13.CrossRefPubMed
45.
Zurück zum Zitat Juneja M, Baidoo L, Schwartz MB, Barrie A, Regueiro M, Dunn M, et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci. 2012;57:2408–15.CrossRefPubMed Juneja M, Baidoo L, Schwartz MB, Barrie A, Regueiro M, Dunn M, et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci. 2012;57:2408–15.CrossRefPubMed
46.
Zurück zum Zitat Riegler G, Tartaglione MT, Carratu R, et al. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci. 2000;45:462–5.CrossRefPubMed Riegler G, Tartaglione MT, Carratu R, et al. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci. 2000;45:462–5.CrossRefPubMed
47.
Zurück zum Zitat Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, Dubinsky M, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009;41:1335–40.CrossRefPubMedPubMedCentral Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, Dubinsky M, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009;41:1335–40.CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PMA, Imielinski M, Guthery SL, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet. 2008;40:1211–5.CrossRefPubMedPubMedCentral Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PMA, Imielinski M, Guthery SL, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet. 2008;40:1211–5.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Levine A, Kugathasan S, Annese V, Biank V, Leshinsky-Silver E, Davidovich O, et al. Pediatric-onset Crohn’s colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis. 2007;13:1509–15.CrossRefPubMed Levine A, Kugathasan S, Annese V, Biank V, Leshinsky-Silver E, Davidovich O, et al. Pediatric-onset Crohn’s colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis. 2007;13:1509–15.CrossRefPubMed
50.
Zurück zum Zitat Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033–45.CrossRefPubMedPubMedCentral Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033–45.CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Moran CJ, Walters TD, Guo CH, Kugathasan S, Klein C, Turner D, et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis. 2013;19:115–23.CrossRefPubMed Moran CJ, Walters TD, Guo CH, Kugathasan S, Klein C, Turner D, et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis. 2013;19:115–23.CrossRefPubMed
52.
Zurück zum Zitat Connelly TM, Berg AS, Harris L III, Brinton D, Deiling S, Koltun WA. Genetic determinants associated with early age diagnosis of IBD. Dis Colon Rectum. 2015;58:321–7.CrossRefPubMed Connelly TM, Berg AS, Harris L III, Brinton D, Deiling S, Koltun WA. Genetic determinants associated with early age diagnosis of IBD. Dis Colon Rectum. 2015;58:321–7.CrossRefPubMed
53.
Zurück zum Zitat Kelsen JR, Grossman AB, Pauly-Hubbard H, Gupta K, Baldassano RN, Mamula P. Infliximab therapy in pediatric patients 7 years of age and younger. J Pediatr Gastroenterol Nutr. 2014;59:758–62.CrossRefPubMed Kelsen JR, Grossman AB, Pauly-Hubbard H, Gupta K, Baldassano RN, Mamula P. Infliximab therapy in pediatric patients 7 years of age and younger. J Pediatr Gastroenterol Nutr. 2014;59:758–62.CrossRefPubMed
54.
Zurück zum Zitat Chhaya V, Pollok RCG, Cecil E, Subramanian V, Curcin V, Majeed A, et al. Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population-based study. Aliment Pharmacol Ther. 2015;42:990–9.CrossRefPubMed Chhaya V, Pollok RCG, Cecil E, Subramanian V, Curcin V, Majeed A, et al. Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population-based study. Aliment Pharmacol Ther. 2015;42:990–9.CrossRefPubMed
55.
Zurück zum Zitat Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr. 2000;31:8–15.CrossRefPubMed Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr. 2000;31:8–15.CrossRefPubMed
56.
Zurück zum Zitat Ruemmele FM, Roy CC, Levy F, et al. Nutrition as primary therapy in pediatric Crohn’s disease: fact or fantasy? J Pediatri. 2000;136:285–91.CrossRef Ruemmele FM, Roy CC, Levy F, et al. Nutrition as primary therapy in pediatric Crohn’s disease: fact or fantasy? J Pediatri. 2000;136:285–91.CrossRef
57.
Zurück zum Zitat Suskind DL, Wahbeh G, Cohen SA, Damman CJ, Klein J, Braly K, et al. Patients perceive clinical benefit with the specific carbohydrate diet for inflammatory bowel disease. Dig Dis Sci. 2016;61:3255–60.CrossRefPubMed Suskind DL, Wahbeh G, Cohen SA, Damman CJ, Klein J, Braly K, et al. Patients perceive clinical benefit with the specific carbohydrate diet for inflammatory bowel disease. Dig Dis Sci. 2016;61:3255–60.CrossRefPubMed
58.
Zurück zum Zitat Obih C, Wahbeh G, Lee D, Braly K, Giefer M, Shaffer ML, et al. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2016;32:418–25.CrossRefPubMed Obih C, Wahbeh G, Lee D, Braly K, Giefer M, Shaffer ML, et al. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2016;32:418–25.CrossRefPubMed
59.
Zurück zum Zitat Engstrom I. Inflammatory bowel disease in children and adolescent: mental health and family functioning. J Pediatr Gastroenterol Nutr. 1999;28:S28–33.CrossRefPubMed Engstrom I. Inflammatory bowel disease in children and adolescent: mental health and family functioning. J Pediatr Gastroenterol Nutr. 1999;28:S28–33.CrossRefPubMed
60.
Zurück zum Zitat Parian A, Ha CY. Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1392–400.PubMed Parian A, Ha CY. Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1392–400.PubMed
61.
Zurück zum Zitat Cucchiara S, Lebba V, Conte MP, et al. The microbiota in inflammatory bowel disease in different age groups. Dig Dis Sci. 2009;27:252–8.CrossRef Cucchiara S, Lebba V, Conte MP, et al. The microbiota in inflammatory bowel disease in different age groups. Dig Dis Sci. 2009;27:252–8.CrossRef
62.
Zurück zum Zitat Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128:92–105.CrossRefPubMed Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128:92–105.CrossRefPubMed
63.
Zurück zum Zitat Cambier J. Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling. Immunol Rev. 2005;205:50–6.CrossRef Cambier J. Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling. Immunol Rev. 2005;205:50–6.CrossRef
64.
Zurück zum Zitat Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6–14.CrossRefPubMedPubMedCentral Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6–14.CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Kim M, Katz S, Green J. Drug management in the elderly IBD patient. Curr Treat Options Gastroenterol. 2015;13:90–104.CrossRefPubMed Kim M, Katz S, Green J. Drug management in the elderly IBD patient. Curr Treat Options Gastroenterol. 2015;13:90–104.CrossRefPubMed
66.
Zurück zum Zitat Katz S, Surawicz C, Pardi DS. Management of the elderly patients with inflammatory bowel disease: practical considerations. Inflamm Bowel Dis. 2013;19:2257–72.CrossRefPubMed Katz S, Surawicz C, Pardi DS. Management of the elderly patients with inflammatory bowel disease: practical considerations. Inflamm Bowel Dis. 2013;19:2257–72.CrossRefPubMed
67.
Zurück zum Zitat Cottone M, Kohn A, Daperno M, Armuzzi A, Guidi L, D'Inca R, et al. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9:30–5.CrossRefPubMed Cottone M, Kohn A, Daperno M, Armuzzi A, Guidi L, D'Inca R, et al. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9:30–5.CrossRefPubMed
68.
Zurück zum Zitat Desai AI, Zator ZA, deSilva P, et al. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:309–15.CrossRefPubMed Desai AI, Zator ZA, deSilva P, et al. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:309–15.CrossRefPubMed
69.
Zurück zum Zitat Lobaton T, Ferrante M, Rutgeerts P, et al. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42:441–51.CrossRefPubMed Lobaton T, Ferrante M, Rutgeerts P, et al. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42:441–51.CrossRefPubMed
70.
Zurück zum Zitat Beaugeri L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617–25.CrossRef Beaugeri L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617–25.CrossRef
71.
Zurück zum Zitat Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients inflammatory bowel disease. Gastroenterology. 2008;134:929–36.CrossRefPubMed Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients inflammatory bowel disease. Gastroenterology. 2008;134:929–36.CrossRefPubMed
72.
Zurück zum Zitat Everhov AH, Halfvarson J, Myrelid P, et al. Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden. Gastroenterology. 2017:1–11. Everhov AH, Halfvarson J, Myrelid P, et al. Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden. Gastroenterology. 2017:1–11.
73.
Zurück zum Zitat Schaefer ME, Machan JT, Kawatu D, Langton CR, Markowitz J, Crandall W, et al. Factors that determine risk for surgery in pediatric patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2010;8:789–94.CrossRefPubMed Schaefer ME, Machan JT, Kawatu D, Langton CR, Markowitz J, Crandall W, et al. Factors that determine risk for surgery in pediatric patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2010;8:789–94.CrossRefPubMed
74.
Zurück zum Zitat Nordenvall C, Rosvall O, Bottai M. Surgical treatment in childhood-onset inflammatory bowel disease—a nationwide register-based study of 4695 incident patients in Sweden 2002-2014. J Crohns Colitis. 2018;12:157–66.CrossRefPubMed Nordenvall C, Rosvall O, Bottai M. Surgical treatment in childhood-onset inflammatory bowel disease—a nationwide register-based study of 4695 incident patients in Sweden 2002-2014. J Crohns Colitis. 2018;12:157–66.CrossRefPubMed
75.
Zurück zum Zitat Stokes AL, Kulaylat AN, Rocourt DV, et al. Rates and trends for inpatient surgeries in pediatric Crohn’s disease in the United States form 2003-2012. J Pediatr Surg 2017. Stokes AL, Kulaylat AN, Rocourt DV, et al. Rates and trends for inpatient surgeries in pediatric Crohn’s disease in the United States form 2003-2012. J Pediatr Surg 2017.
76.
Zurück zum Zitat Nguyen G, Berstein CN, Benchimol EI. Risk of surgery and mortality in elderly-onset inflammatory bowel disease: a population-based cohort study. Inflamm Bowel Dis. 2017;23:218–23.CrossRefPubMed Nguyen G, Berstein CN, Benchimol EI. Risk of surgery and mortality in elderly-onset inflammatory bowel disease: a population-based cohort study. Inflamm Bowel Dis. 2017;23:218–23.CrossRefPubMed
77.
Zurück zum Zitat Ananthakrishnan AN, Shi HY, Tang W, Law CCY, Sung JJY, Chan FKL, et al. Systematic review and meta-analysis: phenotype and clinical outcomes of older-onset inflammatory bowel disease. J Crohns Colitis. 2016;10:1224–36.CrossRefPubMedPubMedCentral Ananthakrishnan AN, Shi HY, Tang W, Law CCY, Sung JJY, Chan FKL, et al. Systematic review and meta-analysis: phenotype and clinical outcomes of older-onset inflammatory bowel disease. J Crohns Colitis. 2016;10:1224–36.CrossRefPubMedPubMedCentral
78.
Zurück zum Zitat Bewtra M, Newcomb CW, Wu Q, Chen L, Xie F, Roy JA, et al. Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study. Ann Intern Med. 2015;163:262–70.CrossRefPubMedPubMedCentral Bewtra M, Newcomb CW, Wu Q, Chen L, Xie F, Roy JA, et al. Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study. Ann Intern Med. 2015;163:262–70.CrossRefPubMedPubMedCentral
79.
Zurück zum Zitat John ES, Katz K, Saxena M, Chokhavatia S, Katz S. Management of inflammatory bowel disease in the elderly. Curr Treat Options Gastroenterol. 2016;14:285–304.CrossRefPubMed John ES, Katz K, Saxena M, Chokhavatia S, Katz S. Management of inflammatory bowel disease in the elderly. Curr Treat Options Gastroenterol. 2016;14:285–304.CrossRefPubMed
80.
Zurück zum Zitat Bollegala N, Jackson TD, Nguyen GC. Increased postoperative mortality, and complications among elderly patients with inflammatory bowel disease: an analysis of the national surgical quality improvement program cohort. Clin Gastroenterol Hepatol. 2016;14:1274–81.CrossRefPubMed Bollegala N, Jackson TD, Nguyen GC. Increased postoperative mortality, and complications among elderly patients with inflammatory bowel disease: an analysis of the national surgical quality improvement program cohort. Clin Gastroenterol Hepatol. 2016;14:1274–81.CrossRefPubMed
81.
Zurück zum Zitat Alexakis C, Saxena S, Chhaya V, Cecil E, Curcin V, Pollok R. Do thiopurines reduce the risk of surgery in elderly onset inflammatory bowel disease? A 20-year national population-based cohort study. Inflamm Bowel Dis. 2017;23:672–80.CrossRefPubMed Alexakis C, Saxena S, Chhaya V, Cecil E, Curcin V, Pollok R. Do thiopurines reduce the risk of surgery in elderly onset inflammatory bowel disease? A 20-year national population-based cohort study. Inflamm Bowel Dis. 2017;23:672–80.CrossRefPubMed
82.
Zurück zum Zitat Kotlyar DS, Lewis JD, Beaugerie L, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2014;13:847–58.CrossRefPubMed Kotlyar DS, Lewis JD, Beaugerie L, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2014;13:847–58.CrossRefPubMed
83.
Zurück zum Zitat Kochar B, Long MD, Galanko J, Raffals LE, Ananthakrishnan A, Sandler RS. Inflammatory bowel disease is similar in patients with older onset and younger onset. Inflamm Bowel Dis. 2017;23:1187–94.CrossRefPubMed Kochar B, Long MD, Galanko J, Raffals LE, Ananthakrishnan A, Sandler RS. Inflammatory bowel disease is similar in patients with older onset and younger onset. Inflamm Bowel Dis. 2017;23:1187–94.CrossRefPubMed
84.
Zurück zum Zitat •• Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease. J Clin Gastroenterol. 2012;46:581–9. Summarizes disease characteristics and management of pediatric-onset of IBD.CrossRefPubMedPubMedCentral •• Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease. J Clin Gastroenterol. 2012;46:581–9. Summarizes disease characteristics and management of pediatric-onset of IBD.CrossRefPubMedPubMedCentral
85.
Zurück zum Zitat Dulai PS, Thompson KD, Blunt H, et al. Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review. Clin Gastroenterol Hepatol. 2014;12:1443–51.CrossRefPubMed Dulai PS, Thompson KD, Blunt H, et al. Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review. Clin Gastroenterol Hepatol. 2014;12:1443–51.CrossRefPubMed
86.
Zurück zum Zitat Kotlyar DS, Osterman MT, Diamond RH, Porter D, Blonski WC, Wasik M, et al. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patient with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9:36–41.CrossRefPubMed Kotlyar DS, Osterman MT, Diamond RH, Porter D, Blonski WC, Wasik M, et al. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patient with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9:36–41.CrossRefPubMed
87.
Zurück zum Zitat de Ridder L, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, et al. Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the Porto Pediatric IBD Group. Inflamm Bowel Dis. 2014;20:291–300.CrossRefPubMed de Ridder L, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, et al. Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the Porto Pediatric IBD Group. Inflamm Bowel Dis. 2014;20:291–300.CrossRefPubMed
88.
Zurück zum Zitat Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, et al. CESAME Study Group. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617–25.CrossRefPubMed Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, et al. CESAME Study Group. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617–25.CrossRefPubMed
89.
Zurück zum Zitat Cheddani H, Dauchet L, Fumery M, et al. Cancer in elderly onset inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2016;111:1428–36.CrossRefPubMed Cheddani H, Dauchet L, Fumery M, et al. Cancer in elderly onset inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2016;111:1428–36.CrossRefPubMed
90.
Zurück zum Zitat Wang YR, Cangemi JR, Loftus EV Jr, et al. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol. 2013;108:444–9.CrossRefPubMed Wang YR, Cangemi JR, Loftus EV Jr, et al. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol. 2013;108:444–9.CrossRefPubMed
91.
Zurück zum Zitat Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determine therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324–38.CrossRefPubMed Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determine therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324–38.CrossRefPubMed
92.
Zurück zum Zitat Kim SC, Ferry GD. Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology. 2004;126:1550–60.CrossRefPubMed Kim SC, Ferry GD. Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology. 2004;126:1550–60.CrossRefPubMed
93.
Zurück zum Zitat Afzali A, Wahbeh G. Transition of pediatric to adult care in inflammatory bowel disease: is it as easy as 1, 2, 3? World J Gastroenterol. 2017;23:3624–31.CrossRefPubMedPubMedCentral Afzali A, Wahbeh G. Transition of pediatric to adult care in inflammatory bowel disease: is it as easy as 1, 2, 3? World J Gastroenterol. 2017;23:3624–31.CrossRefPubMedPubMedCentral
94.
Zurück zum Zitat Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patient with multiple conditions. N Engl J Med. 2004;351:2870–4.CrossRefPubMed Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patient with multiple conditions. N Engl J Med. 2004;351:2870–4.CrossRefPubMed
95.
Zurück zum Zitat Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS. Risk factors for depression in the elderly inflammatory bowel disease population. J Crohns Colitis. 2014;8:113–9.CrossRefPubMed Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS. Risk factors for depression in the elderly inflammatory bowel disease population. J Crohns Colitis. 2014;8:113–9.CrossRefPubMed
Metadaten
Titel
Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD
verfasst von
Anita Afzali, MD, MPH, FACG
Seymour Katz, MD, FACP, MACG
Publikationsdatum
13.07.2018
Verlag
Springer US
Erschienen in
Current Treatment Options in Gastroenterology / Ausgabe 3/2018
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-018-0188-9

Weitere Artikel der Ausgabe 3/2018

Current Treatment Options in Gastroenterology 3/2018 Zur Ausgabe

Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)

Outcomes and Management of the Ileal Pouch-Anal Anastomosis in the Elderly

Endoscopy (P Siersema, Section Editor)

Training in Endoscopy

Pancreas (V Chandrasekhara, Section Editor)

Diagnosis and Management of Exocrine Pancreatic Insufficiency

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.